Announcements Trials
Browse Landscape

Status

Completed 37Terminated 5Recruiting 3Not yet recruiting 2Withdrawn 1Unknown 1No longer available 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Plasma cell 18Lymphoid 3Other hematologic neoplasm 2Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 305Lymphoma, Non-Hodgkin 226Lymphoma, Large B-Cell, Diffuse 220Lymphoma, Follicular 200Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 148Recurrence 124Burkitt Lymphoma 117Lymphoma, Mantle-Cell 112Leukemia, Myeloid, Acute 106Leukemia 102Hodgkin Disease 102Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 87Neoplasms 80Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 62Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 51Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 41Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 31Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Monoclonal Gammopathy of Undetermined Significance × Lymphoid × Clear all
NCT02269592 2026-05-07

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Dana-Farber Cancer Institute

Recruiting
10,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT06895291 2025-03-30

ONCO-MRI

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Recruiting
1,000 enrolled
LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Peking University First Hospital

Recruiting
2,000 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡